Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sonal Temburni-Blake

3PUBLICATIONS
14CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 11, 2024
Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.

Arianna Moiani, Gil Letort, Sabrina Lizot

|May 09, 2020
Author Correction: Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality.

Mohit Sachdeva, Brian W Busser, Sonal Temburni

|Nov 15, 2019
Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality.

Mohit Sachdeva, Brian W Busser, Sonal Temburni

Pageof 1

Frequent Collaborators

3 joint publications

Alexandre Juillerat

3 joint publications

Philippe Duchateau

3 joint publications

Julien Valton

2 joint publications

Billal Jahangiri

2 joint publications

Laurent Poirot

1 joint publications

Gil Letort

1 joint publications

Anne Chalumeau

1 joint publications

Tristan Felix

1 joint publications

Sophie Leduc

1 joint publications

Eduardo Seclen

Frequent Collaborators

3 joint publications

Alexandre Juillerat

3 joint publications

Philippe Duchateau

3 joint publications

Julien Valton

2 joint publications

Billal Jahangiri

Top Related Videos

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on : Oct 03, 2019

12.2K
Non-Viral Engineering of Primary Human T Cells <em>via</em> Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells <em>via</em> Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on : May 09, 2025

794
See more related videos

Top Related Videos

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on : Oct 03, 2019

12.2K
Non-Viral Engineering of Primary Human T Cells <em>via</em> Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells <em>via</em> Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on : May 09, 2025

794
See more related videos